Mesenchymal Stem Cell-Derived Exosomes Hold Promise in the Treatment of Diabetic Foot Ulcers
Hui Wang,1,* Sensen Wu,1,* Xinyu Bai,2 Dikang Pan,1 Yachan Ning,1 Cong Wang,1 Lianrui Guo,1 Jianming Guo,1 Yongquan Gu1 1Department of Vascular Surgery, Xuanwu Hospital, Capital Medical University, Beijing, 100053, People’s Republic of China; 2Department of Ophthalmology, The...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-05-01
|
| Series: | International Journal of Nanomedicine |
| Subjects: | |
| Online Access: | https://www.dovepress.com/mesenchymal-stem-cell-derived-exosomes-hold-promise-in-the-treatment-o-peer-reviewed-fulltext-article-IJN |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850274025482223616 |
|---|---|
| author | Wang H Wu S Bai X Pan D Ning Y Wang C Guo L Guo J Gu Y |
| author_facet | Wang H Wu S Bai X Pan D Ning Y Wang C Guo L Guo J Gu Y |
| author_sort | Wang H |
| collection | DOAJ |
| description | Hui Wang,1,* Sensen Wu,1,* Xinyu Bai,2 Dikang Pan,1 Yachan Ning,1 Cong Wang,1 Lianrui Guo,1 Jianming Guo,1 Yongquan Gu1 1Department of Vascular Surgery, Xuanwu Hospital, Capital Medical University, Beijing, 100053, People’s Republic of China; 2Department of Ophthalmology, The Second Hospital of Jilin University, Changchun, Jilin Province, 130033, People’s Republic of China*These authors contributed equally to this workCorrespondence: Yongquan Gu; Jianming Guo, Department of Vascular Surgery, Xuanwu Hospital, Capital Medical University, No. 45, Changchun Street, Beijing, 100053, People’s Republic of China, Tel +86 15311614369, Email gu15901598209@aliyun.com; jianmingguoxuanwu@163.comAbstract: Diabetic foot ulcers (DFU) represent one of the most common side effects of diabetes, significantly impacting patients’ quality of life and imposing considerable financial burdens on families and society at large. Despite advancements in therapies targeting lower limb revascularization and various medications and dressings, outcomes for patients with severe lesions remain limited. A recent breakthrough in DFU treatment stems from the development of mesenchymal stem cells (MSCs). MSCs have shown promising results in treating various diseases and skin wounds due to their ability for multidirectional differentiation and immunomodulation. Recent studies highlight that MSCs primarily repair tissue through their paracrine activities, with exosomes playing a crucial role as the main biologically active components. These exosomes transport proteins, mRNA, DNA, and other substances, facilitating DFU treatment through immunomodulation, antioxidant effects, angiogenesis promotion, endothelial cell migration and proliferation, and collagen remodeling. Mesenchymal stem cell-derived exosomes (MSC-Exo) not only deliver comparable therapeutic effects to MSCs but also mitigate adverse reactions like immune rejection associated with MSCs transplantation. This article provides an overview of DFU pathophysiology and explores the mechanisms and research progress of MSC-Exo in DFU therapy. Keywords: diabetic foot ulcer, DFU, mesenchymal stem cells, MSCs, exosomes, skin repair, regeneration, angiogenesis |
| format | Article |
| id | doaj-art-455e735f06c7423c9835a17c7e14f2e4 |
| institution | OA Journals |
| issn | 1178-2013 |
| language | English |
| publishDate | 2025-05-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | International Journal of Nanomedicine |
| spelling | doaj-art-455e735f06c7423c9835a17c7e14f2e42025-08-20T01:51:16ZengDove Medical PressInternational Journal of Nanomedicine1178-20132025-05-01Volume 20Issue 158375857102708Mesenchymal Stem Cell-Derived Exosomes Hold Promise in the Treatment of Diabetic Foot UlcersWang HWu SBai XPan D0Ning YWang CGuo LGuo J1Gu Yvascular surgeryVascular SurgeryHui Wang,1,* Sensen Wu,1,* Xinyu Bai,2 Dikang Pan,1 Yachan Ning,1 Cong Wang,1 Lianrui Guo,1 Jianming Guo,1 Yongquan Gu1 1Department of Vascular Surgery, Xuanwu Hospital, Capital Medical University, Beijing, 100053, People’s Republic of China; 2Department of Ophthalmology, The Second Hospital of Jilin University, Changchun, Jilin Province, 130033, People’s Republic of China*These authors contributed equally to this workCorrespondence: Yongquan Gu; Jianming Guo, Department of Vascular Surgery, Xuanwu Hospital, Capital Medical University, No. 45, Changchun Street, Beijing, 100053, People’s Republic of China, Tel +86 15311614369, Email gu15901598209@aliyun.com; jianmingguoxuanwu@163.comAbstract: Diabetic foot ulcers (DFU) represent one of the most common side effects of diabetes, significantly impacting patients’ quality of life and imposing considerable financial burdens on families and society at large. Despite advancements in therapies targeting lower limb revascularization and various medications and dressings, outcomes for patients with severe lesions remain limited. A recent breakthrough in DFU treatment stems from the development of mesenchymal stem cells (MSCs). MSCs have shown promising results in treating various diseases and skin wounds due to their ability for multidirectional differentiation and immunomodulation. Recent studies highlight that MSCs primarily repair tissue through their paracrine activities, with exosomes playing a crucial role as the main biologically active components. These exosomes transport proteins, mRNA, DNA, and other substances, facilitating DFU treatment through immunomodulation, antioxidant effects, angiogenesis promotion, endothelial cell migration and proliferation, and collagen remodeling. Mesenchymal stem cell-derived exosomes (MSC-Exo) not only deliver comparable therapeutic effects to MSCs but also mitigate adverse reactions like immune rejection associated with MSCs transplantation. This article provides an overview of DFU pathophysiology and explores the mechanisms and research progress of MSC-Exo in DFU therapy. Keywords: diabetic foot ulcer, DFU, mesenchymal stem cells, MSCs, exosomes, skin repair, regeneration, angiogenesishttps://www.dovepress.com/mesenchymal-stem-cell-derived-exosomes-hold-promise-in-the-treatment-o-peer-reviewed-fulltext-article-IJNdiabetic foot ulcer (DFU)Mesenchymal stem cells (MSCs)exosomesskin repairregenerationangiogenesis |
| spellingShingle | Wang H Wu S Bai X Pan D Ning Y Wang C Guo L Guo J Gu Y Mesenchymal Stem Cell-Derived Exosomes Hold Promise in the Treatment of Diabetic Foot Ulcers International Journal of Nanomedicine diabetic foot ulcer (DFU) Mesenchymal stem cells (MSCs) exosomes skin repair regeneration angiogenesis |
| title | Mesenchymal Stem Cell-Derived Exosomes Hold Promise in the Treatment of Diabetic Foot Ulcers |
| title_full | Mesenchymal Stem Cell-Derived Exosomes Hold Promise in the Treatment of Diabetic Foot Ulcers |
| title_fullStr | Mesenchymal Stem Cell-Derived Exosomes Hold Promise in the Treatment of Diabetic Foot Ulcers |
| title_full_unstemmed | Mesenchymal Stem Cell-Derived Exosomes Hold Promise in the Treatment of Diabetic Foot Ulcers |
| title_short | Mesenchymal Stem Cell-Derived Exosomes Hold Promise in the Treatment of Diabetic Foot Ulcers |
| title_sort | mesenchymal stem cell derived exosomes hold promise in the treatment of diabetic foot ulcers |
| topic | diabetic foot ulcer (DFU) Mesenchymal stem cells (MSCs) exosomes skin repair regeneration angiogenesis |
| url | https://www.dovepress.com/mesenchymal-stem-cell-derived-exosomes-hold-promise-in-the-treatment-o-peer-reviewed-fulltext-article-IJN |
| work_keys_str_mv | AT wangh mesenchymalstemcellderivedexosomesholdpromiseinthetreatmentofdiabeticfootulcers AT wus mesenchymalstemcellderivedexosomesholdpromiseinthetreatmentofdiabeticfootulcers AT baix mesenchymalstemcellderivedexosomesholdpromiseinthetreatmentofdiabeticfootulcers AT pand mesenchymalstemcellderivedexosomesholdpromiseinthetreatmentofdiabeticfootulcers AT ningy mesenchymalstemcellderivedexosomesholdpromiseinthetreatmentofdiabeticfootulcers AT wangc mesenchymalstemcellderivedexosomesholdpromiseinthetreatmentofdiabeticfootulcers AT guol mesenchymalstemcellderivedexosomesholdpromiseinthetreatmentofdiabeticfootulcers AT guoj mesenchymalstemcellderivedexosomesholdpromiseinthetreatmentofdiabeticfootulcers AT guy mesenchymalstemcellderivedexosomesholdpromiseinthetreatmentofdiabeticfootulcers |